neuroClues verkrijgt CE-certificering voor zijn eye-tracking technologie die de neurologische zorg moet verbeteren
Volgende stap: neuroClues op de Europese markt lanceren en de “stethoscoop van de hersenen” worden Samengevat neuroClues behaalt MDR-certificering (Medical Device Regulation) en mag nu het CE-merk voeren op zijn Klasse IIa medisch hulpmiddel dat is ontworpen om de neurologische zorg te verbeteren met biomarkers voor oogbewegingen. Na meer dan 60 jaar onderzoek door […]
neuroClues secures CE certification for its eye-tracking technology set to enhance neurologic care
In summary neuroClues achieves Medical Device Regulation (MDR) certification and is now allowed to issue the CE-mark on its Class IIa medical device designed to enhance neurologic care with eye movement biomarkers. Its solution has been designed to bring to clinical practice a wealth of over 60 years of research. The company is setting […]
NeuroClues™ (P3Lab) awarded funding from the European Commission through the prestigious EIC Accelerator Program
In summary P3Lab is one of the 78 companies selected among 1092 applicants by the European program EIC Accelerator. The funds will enable the company to accelerate the go-to-market of neuroCluesTM, the all-in-one eye tracking solution that will empower clinicians with Biomarkers allowing them to identify Neurological Disorders years before visible symptoms. P3Lab rebrands as […]
